AGP Picks
View all

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on October 15, 2026

DIAL3D Partners with Opus on AI Admissions for Behavioral Health
Love and Legend Lolli to Speak at the Biohackers World Conference in Miami
Everstory Partners Expands Everstory University Beyond Its Workforce
Cosmo Direct Supply Highlights New Menopause Skin Research and Sculptra Protocols for Clinics
PlanScout Launches Free Medicare Coverage Guide as Open Enrollment Begins
Loyal Source Government Services Selects Jody Carpenter as Senior Director, Operational Excellence
The Hustle Grant Funds Fort Pierce Attorney's Community Workshop to Bring "Clarity, Not Confusion" to Estate Planning
Paretofit Announces Founder Tobias Burkhardt's Feature in Prime Today on Sustainable Performance for Entrepreneurs
Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors
Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026
Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bispecific Antibody, and Initiation of Additional ADC…
LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
Données Complètes à 12 Mois de l’Étude Pivot Américaine ACCCESS chez les Patients Atteints de Collapsus Concentrique Complet Présentées à l’ISSS 2026
Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
LB Pharmaceuticals to Participate in Upcoming Investor Events
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Florida Health Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.